{
    "2020-03-13": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Germany's CureVac says low-dose coronavirus vaccine could allow for mass production",
                "features": {
                    "keywords": [
                        "CureVac",
                        "low-dose",
                        "coronavirus",
                        "vaccine",
                        "mass production"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-02",
                "original_text": "Pfizer Outlines Five-Point Plan to Battle COVID-19",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Five-Point Plan",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-03",
                "original_text": "EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study",
                "features": {
                    "keywords": [
                        "EMD Serono",
                        "Pfizer",
                        "Phase III",
                        "JAVELIN",
                        "Head and Neck 100 Study"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pfizer",
                        "Phase III",
                        "JAVELIN",
                        "Head and Neck 100 Study"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "Pfizer Stock Rises 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock",
                        "Rises",
                        "3%"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}